Key result
Heparin administration for deep vein thrombosis in a hemodialysis patient with uremia resulted in hemopericardium with cardiac tamponade and life-threatening hyperkalemia.
Case Report (n=1)
Heparin therapy in hemodialysis patients can rarely lead to severe complications such as cardiac tamponade and life-threatening hyperkalemia.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare tamponade risk with heparin in uremic hemodialysis; case report leaves open incidence and causality.
Heparin, a commonly used anticoagulant agent, is frequently used in patients undergoing hemodialysis. As with most medications, heparin has a significant side effect profile. Two of its most important side effects, major bleeding and hyperkalemia, may be devastating without immediate diagnosis and treatment. Major bleeding such as gastrointestinal, genitourinary or intracranial bleeding is occasionally encountered and rarely neglected. However, heparin-induced cardiac tamponade is rarely encountered and may be easily overlooked. Another side effect, heparin-induced hyperkalemia, an unusual but well-described side effect, is frequently forgotten until life-threatening arrhythmia has occurred. We report a case involving a 40-year-old male patient with uremia, who had received heparin for 10 days for deep vein thrombosis in the left lower extremity. Hemopericardium with cardiac tamponade and life-threatening hyperkalemia were both noted in this patient.
No takes yet. Share an insight, caveat, or question.
Su et al. (2005) conducted a case report in Uremia and deep vein thrombosis (n=1). Heparin was evaluated on Hemopericardium with cardiac tamponade and life-threatening hyperkalemia. Heparin administration for deep vein thrombosis in a hemodialysis patient with uremia resulted in hemopericardium with cardiac tamponade and life-threatening hyperkalemia.
Synapse has enriched 10 related papers. Consider them for comparative context: